• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量表观扩散系数在鉴别肝硬化中分类为LI-RADS 3和4类的良性结节与小肝细胞癌方面的附加价值

Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis.

作者信息

Zhong Xi, Tang Hongsheng, Guan Tianpei, Lu Bingui, Zhang Chuangjia, Tang Danlei, Li Jiansheng, Cui Shuzhong

机构信息

Department of Medical Imaging, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.

Department of Abdominal Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.

出版信息

J Clin Transl Hepatol. 2022 Feb 28;10(1):34-41. doi: 10.14218/JCTH.2021.00053. Epub 2021 May 28.

DOI:10.14218/JCTH.2021.00053
PMID:35233371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8845165/
Abstract

BACKGROUND AND AIMS

Correct identification of small hepatocellular carcinomas (HCCs) and benign nodules in cirrhosis remains challenging, quantitative apparent diffusion coefficients (ADCs) have shown potential value in characterization of benign and malignant liver lesions. We aimed to explore the added value of ADCs in the identification of small (≤3 cm) HCCs and benign nodules categorized as Liver Imaging Reporting and Data System (LI-RADS) 3 (LR-3) and 4 (LR-4) in cirrhosis.

METHODS

Ninety-seven cirrhosis patients with 109 small nodules (70 HCCs, 39 benign nodules) of LR-3 and 4 LR-4 based on major and ancillary magnetic resonance imaging features were included. Multiparametric quantitative ADCs of the lesions, including the mean ADC (ADC), minimum ADC (ADC), maximal ADC (ADC), ADC standard deviation (ADC), and mean ADC value ratio of lesion-to-liver parenchyma (ADC) were calculated. Regarding the joint diagnosis, a nomogram model was plotted using multivariate logistic regression analysis. The performance was assessed using the area under the receiver operating characteristic curve (AUC).

RESULTS

The ADC, ADC, ADC, and ADC were significantly associated with the identification of small HCC and benign nodules (<0.001). For the joint diagnosis, the LI-RADS category (odds ratio [OR]=12.50), ADC (OR=0.14), and ADC (OR=0.12) were identified as independent factors for distinguishing HCCs from benign nodules. The joint nomogram model showed good calibration and discrimination, with a C-index of 0.947. Compared with the LI-RADS category alone, this nomogram model demonstrated a significant improvement in diagnostic performance, with AUC increasing from 0.820 to 0.967 (=0.001).

CONCLUSIONS

The addition of quantitative ADCs could improve the identification of small HCC and benign nodules categorized as LR-3 and 4 LR-4 in patients with cirrhosis.

摘要

背景与目的

准确鉴别肝硬化中的小肝细胞癌(HCC)和良性结节仍具有挑战性,定量表观扩散系数(ADC)在肝脏良恶性病变的特征描述中已显示出潜在价值。我们旨在探讨ADC在鉴别肝硬化中直径≤3 cm的小HCC以及分类为肝脏影像报告和数据系统(LI-RADS)3类(LR-3)和4类(LR-4)的良性结节方面的附加价值。

方法

纳入97例肝硬化患者,这些患者有基于主要和辅助磁共振成像特征的109个LR-3和LR-4的小结节(70个HCC,39个良性结节)。计算病变的多参数定量ADC,包括平均ADC(ADC)、最小ADC(ADC)、最大ADC(ADC)、ADC标准差(ADC)以及病变与肝实质的平均ADC值比(ADC)。关于联合诊断,使用多变量逻辑回归分析绘制列线图模型。使用受试者操作特征曲线下面积(AUC)评估其性能。

结果

ADC、ADC、ADC和ADC与小HCC和良性结节的鉴别显著相关(<0.001)。对于联合诊断,LI-RADS分类(比值比[OR]=12.50)、ADC(OR=0.14)和ADC(OR=0.12)被确定为区分HCC与良性结节的独立因素。联合列线图模型显示出良好的校准和区分能力,C指数为0.947。与单独的LI-RADS分类相比,该列线图模型在诊断性能上有显著改善,AUC从0.820增加到0.967(=0.001)。

结论

添加定量ADC可改善肝硬化患者中分类为LR-3和LR-4的小HCC和良性结节的鉴别。

相似文献

1
Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis.定量表观扩散系数在鉴别肝硬化中分类为LI-RADS 3和4类的良性结节与小肝细胞癌方面的附加价值
J Clin Transl Hepatol. 2022 Feb 28;10(1):34-41. doi: 10.14218/JCTH.2021.00053. Epub 2021 May 28.
2
Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm.小肝癌(≤3cm)与肝硬化肝脏良性结节的鉴别:基于 MRI 的放射组学分析对 LI-RADS 版本 2018 算法的附加附加价值。
BMC Gastroenterol. 2021 Apr 7;21(1):155. doi: 10.1186/s12876-021-01710-y.
3
Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?仅基于MRI的可疑乳腺病变的定量表观扩散系数指标:有额外的临床价值吗?
Quant Imaging Med Surg. 2023 Oct 1;13(10):7092-7104. doi: 10.21037/qims-23-331. Epub 2023 Sep 12.
4
Radiation-induced occult insufficiency fracture or bone metastasis after radiotherapy for cervical cancer? The nomogram based on quantitative apparent diffusion coefficients for discrimination.宫颈癌放疗后辐射诱导隐匿性不全骨折或骨转移?基于定量表观扩散系数的鉴别列线图
Cancer Imaging. 2020 Oct 23;20(1):76. doi: 10.1186/s40644-020-00353-8.
5
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.LI-RADS v2018 主要特征和辅助特征的批判性分析在使用钆贝葡胺增强磁共振成像鉴别≤2cm 的小肝癌与异型增生结节中的作用。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7786-7801. doi: 10.26355/eurrev_201909_18988.
6
Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.CEUS LI-RADS 在肝癌风险患者中对 20mm 或更小的肝脏结节的特征诊断准确性。
Radiology. 2020 Feb;294(2):329-339. doi: 10.1148/radiol.2019191086. Epub 2019 Dec 3.
7
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.肝脏影像报告和数据系统与磁共振成像:在筛查 US 中检测到肝硬化中 20mm 或更小的结节的评估。
Radiology. 2015 Jun;275(3):698-707. doi: 10.1148/radiol.15141132. Epub 2015 Feb 5.
8
Liver Imaging Reporting and Data System (LI-RADS) v2018: differential diagnostic value of ADC values for benign and malignant nodules with moderate probability (LR-3).肝脏影像报告和数据系统(LI-RADS)v2018:表观扩散系数(ADC)值对中度可能性(LR-3)的良性和恶性结节的鉴别诊断价值
Front Oncol. 2023 Aug 22;13:1186290. doi: 10.3389/fonc.2023.1186290. eCollection 2023.
9
LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI.LI-RADS v2018:如何在钆塞酸增强 MRI 上从中等恶性概率(LR-3)到可能 HCC(LR-4)的类别调整中适当使用辅助特征。
Eur Radiol. 2022 Jan;32(1):46-55. doi: 10.1007/s00330-021-08116-0. Epub 2021 Jun 16.
10
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.

引用本文的文献

1
Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases.弥散加权成像对接受或未接受热灌注腹腔化疗的胃癌伴腹膜转移患者减瘤手术的预后价值
BMC Cancer. 2025 Apr 5;25(1):616. doi: 10.1186/s12885-025-14008-z.
2
Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma.磁共振成像对合并肝细胞癌的 LR-3 和 LR-4 病变的诊断价值。
Abdom Radiol (NY). 2024 Aug;49(8):2629-2638. doi: 10.1007/s00261-024-04338-0. Epub 2024 Jun 5.
3

本文引用的文献

1
[Texture analysis of diffusion-weighted magnetic resonance imaging to identify atypically enhanced small hepatocellular carcinoma and dysplastic nodules under the background of cirrhosis].[磁共振扩散加权成像纹理分析鉴别肝硬化背景下非典型强化小肝细胞癌及发育异常结节]
Zhonghua Gan Zang Bing Za Zhi. 2020 Jan 20;28(1):37-42. doi: 10.3760/cma.j.issn.1007-3418.2020.01.010.
2
Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging.肝硬化肝脏中微小肝细胞癌与发育异常结节的鉴别:基于MRI的纹理分析在与钆塞酸增强磁共振成像和扩散加权成像比较时性能得到改善。
Front Oncol. 2020 Jan 10;9:1382. doi: 10.3389/fonc.2019.01382. eCollection 2019.
3
Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma.
用于预测鼻咽癌程序性死亡配体 1 表达的定量表观扩散系数测量的可重复性和实用性。
Cancer Imaging. 2023 Oct 12;23(1):98. doi: 10.1186/s40644-023-00587-2.
4
Liver Imaging Reporting and Data System (LI-RADS) v2018: differential diagnostic value of ADC values for benign and malignant nodules with moderate probability (LR-3).肝脏影像报告和数据系统(LI-RADS)v2018:表观扩散系数(ADC)值对中度可能性(LR-3)的良性和恶性结节的鉴别诊断价值
Front Oncol. 2023 Aug 22;13:1186290. doi: 10.3389/fonc.2023.1186290. eCollection 2023.
5
Role of radiomics in the diagnosis and treatment of gastrointestinal cancer.影像组学在胃肠癌诊断与治疗中的作用。
World J Gastroenterol. 2022 Nov 14;28(42):6002-6016. doi: 10.3748/wjg.v28.i42.6002.
A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.基于 CT 的影像组学列线图,用于区分无可见脂肪的肾血管平滑肌脂肪瘤与均质透明细胞肾细胞癌。
Eur Radiol. 2020 Feb;30(2):1274-1284. doi: 10.1007/s00330-019-06427-x. Epub 2019 Sep 10.
4
Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRI.通过肝脏MRI选择的葡萄膜黑色素瘤患者肝转移预后列线图的开发。
Cancers (Basel). 2019 Jun 21;11(6):863. doi: 10.3390/cancers11060863.
5
Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.使用放射组学列线图预测适合根治性消融的肝细胞癌早期复发。
Cancer Imaging. 2019 Apr 26;19(1):21. doi: 10.1186/s40644-019-0207-7.
6
LI-RADS Version 2018 Ancillary Features at MRI.LI-RADS Version 2018 磁共振成像辅助特征。
Radiographics. 2018 Nov-Dec;38(7):1973-2001. doi: 10.1148/rg.2018180052. Epub 2018 Oct 5.
7
Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?钆塞酸增强 MRI 中新的肝细胞癌诊断标准的回顾性验证:肝胆期低信号是否可以借助辅助特征替代廓清作为替代方法?
Eur Radiol. 2019 Apr;29(4):1724-1732. doi: 10.1007/s00330-018-5727-1. Epub 2018 Sep 25.
8
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.肝脏影像报告和数据系统(LI-RADS)2018 版:高危患者肝细胞癌的影像学表现。
Radiology. 2018 Dec;289(3):816-830. doi: 10.1148/radiol.2018181494. Epub 2018 Sep 25.
9
Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.基于 CT 影像的放射组学特征预测胃癌患者生存及化疗获益
EBioMedicine. 2018 Oct;36:171-182. doi: 10.1016/j.ebiom.2018.09.007. Epub 2018 Sep 14.
10
The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm).肝脏影像报告和数据系统(LI-RADS)联合超声造影(CEUS)在小肝结节(≤2cm)中的初步应用
J Cancer. 2018 Jul 30;9(16):2946-2952. doi: 10.7150/jca.25539. eCollection 2018.